Earnest Analytics
Provides alternative data and analytics on U.S. consumer and healthcare spending via an AI-powered platform.
Website: https://www.earnestanalytics.com/
PUBLIC
| Name | Earnest Analytics |
| Tagline | Provides alternative data and analytics on U.S. consumer and healthcare spending via an AI-powered platform. |
| Headquarters | New York, NY, United States |
| Founded | 2012 |
| Stage | Exited |
| Business Model | SaaS |
| Industry | Other |
| Technology | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding Label | Undisclosed |
Links
PUBLIC
- Website: https://www.earnestanalytics.com
- LinkedIn: https://www.linkedin.com/company/earnest-analytics
Executive Summary
PUBLIC Earnest Analytics provides a unified alternative data platform for investors and corporations tracking U.S. consumer and healthcare spending, a position recently solidified by its acquisition by Consumer Edge in 2024 [PR Newswire (via Yahoo Finance syndication), Sept 2024]. The company aggregates and analyzes credit card, e-commerce, and medical claims data through its Dash platform, aiming to deliver predictive insights on revenue and market share [LinkedIn]. Founded in 2012 by Kevin Carson and Annalee Bloomfield, the firm evolved from Earnest Research, rebranding in 2022 to reflect a focus on analytics over raw research [PR Newswire, Nov 2022]. Its differentiation lies in combining consumer and healthcare datasets under one roof, supported by analyst services that translate data into actionable intelligence.
Leadership includes CEO Kevin Carson and CRO Alyssa Lewis Matabeek, though co-founder Annalee Bloomfield has since moved to a CEO role at another venture [TechCrunch, Nov 2021]. The company raised a disclosed $18.5 million across a Series A and Series B before its exit, backed by investors including Osage Venture Partners and Greycroft [Crunchbase]. The business model is SaaS, with data delivered via an interactive platform and direct feeds to client systems like Snowflake [Benzinga, 2024]. Over the next 12-18 months, the key watch item is integration execution under Consumer Edge and the traction of newly launched datasets, such as the Hydrus medical claims product, within the combined entity's expanded client base [Pivot Investment Partners, 2025].
Data Accuracy: YELLOW -- Core company facts and acquisition are confirmed by multiple sources; some leadership details rely on single-source profiles.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Exited |
| Business Model | SaaS |
| Industry | Other |
| Technology Type | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
Company Overview
PUBLIC
Founded in 2012, Earnest Analytics operates as a provider of alternative data and analytics, with its headquarters in New York, NY [Crunchbase]. The company, originally named Earnest Research, underwent a formal rebranding to Earnest Analytics in November 2022, a move it stated better reflected its evolution into a platform delivering data and insights for the consumer and healthcare economy [PR Newswire, Nov 2022]. The firm's development appears to have been venture-backed, with a Series A round closed in August 2014 and a Series B in September 2019 [Crunchbase, 2026].
A significant corporate milestone was reached in September 2024 when Consumer Edge, a provider of global consumer transaction data, announced a definitive agreement to acquire Earnest Analytics [PR Newswire, Sept 2024]. The acquisition was framed as a strategic move to combine datasets and strengthen intelligence offerings for a global client base. The transaction closed on April 14, 2025, marking an exit for Earnest's earlier investors [Crunchbase].
Data Accuracy: GREEN -- Company founding, rebrand, acquisition, and funding dates confirmed by multiple public sources including Crunchbase and PR Newswire.
Product and Technology
MIXED
Earnest Analytics provides a dual-layered product suite centered on delivering alternative data and analytics for the U.S. consumer and healthcare economies. The core offering is the AI-powered Dash platform, which aggregates and visualizes multiple proprietary datasets to surface insights for investment and business professionals [LinkedIn] [G2, 2025]. The platform is designed to provide real-time earnings predictions, track sales growth and customer retention, and benchmark market share [LinkedIn]. For users requiring raw data, the company offers Earnest Direct, a row-level data feed delivered via cloud platforms like Snowflake and AWS [Benzinga, 2024]. This structure allows clients to choose between a fully analyzed, interactive experience and direct access to the underlying data for custom modeling.
The breadth of data coverage is a primary differentiator. The company curates what it describes as two leading credit card transaction datasets (Orion and Vela panels), alongside consumer goods pricing, web-scraped e-commerce data, mobile location foot traffic, and healthcare-specific datasets including pharmacy claims, medical procedure data, and prescription drug information [Neudata] [earnestanalytics.com, 2026]. A significant recent addition is the Hydrus medical claims dataset, launched in February 2025, which expands its healthcare vertical [Pivot Investment Partners, 2025]. The platform's value proposition hinges on unifying these diverse sources to give a composite view of consumer and patient spending behavior.
Technically, the platform emphasizes automation, customization, and point-in-time data integrity, which is critical for quantitative backtesting [Research.com, 2026] [earnestanalytics.com, 2026]. While the specific AI and machine learning stack is not detailed publicly, the company's hiring for roles like Senior Analytics Engineer suggests a backend built on modern data engineering and cloud infrastructure (inferred from job postings) [Built In San Francisco]. The product is positioned not as a passive data feed but as an active analytical partner, with expert analyst services integrated to provide custom, actionable insights [earnestanalytics.com].
Data Accuracy: GREEN -- Product features and data coverage are confirmed by multiple independent sources including G2, Neudata, and company press releases.
Market Research
PUBLIC
The appetite for alternative data among institutional investors has moved from a discretionary edge to a core operational requirement, driven by the need for real-time signals in volatile public markets and deeper diligence in private markets.
Direct market sizing for Earnest Analytics' specific niche is not publicly available from third-party reports. However, the broader alternative data market provides a relevant analog. According to a 2023 report from Grand View Research, the global alternative data market size was valued at $7.5 billion and is projected to expand at a compound annual growth rate (CAGR) of 39.5% from 2024 to 2030 [Grand View Research, 2023]. Within this, the consumer and healthcare transaction data segments Earnest focuses on are among the most mature and sought-after categories, historically commanding premium pricing and high renewal rates from hedge funds and long-only asset managers.
Demand is anchored by several persistent tailwinds. The compression of earnings cycles and the rise of direct-to-consumer brands have made traditional quarterly reports insufficient for investors, creating a continuous need for near-real-time spending data [PR Newswire, Nov 2022]. In healthcare, the shift towards value-based care and outcomes measurement has increased demand for procedure-level claims data to analyze provider networks and pharmaceutical adoption. Furthermore, the expansion of data availability beyond pure quantitative funds to mutual funds, private equity, and corporate strategy teams broadens the potential customer base, a trend Earnest's marketing explicitly acknowledges [earnestanalytics.com, 2026].
Adjacent and substitute markets present both risk and opportunity. The primary substitute is traditional sell-side equity research, though its decline in coverage depth, especially for small and mid-cap stocks, has created a vacuum that alternative data providers aim to fill. Adjacent markets include broader business intelligence platforms and data aggregators that may offer similar datasets but lack the sector-specific analytical overlay. The regulatory environment remains a watch item; while anonymized transaction and claims data generally falls outside strict privacy regulations like HIPAA or GDPR, the sourcing and aggregation of such data requires rigorous partner compliance, a point Earnest emphasizes by referencing its "world-class data partners" [earnestanalytics.com].
| Metric | Value |
|---|---|
| Global Alt Data Market 2023 | 7.5 $B |
| Projected CAGR 2024-2030 | 39.5 % |
The cited growth rate underscores the sector's momentum, but investors should note it represents the total addressable market for all alternative data, not Earnest's serviceable obtainable market. The firm's dual focus on consumer and healthcare spending carves out a defensible segment within this high-growth space.
Data Accuracy: YELLOW -- Market sizing is from an analogous third-party report; company-specific segmentation is not publicly confirmed.
Competitive Landscape
MIXED
Earnest Analytics operates in a specialized segment of the alternative data market, competing on the breadth of its integrated consumer and healthcare datasets rather than on raw data volume alone.
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Earnest Analytics | Integrated consumer & healthcare alt-data via Dash platform and analyst services. | Exited (Acquired 2025) | Combines credit card, healthcare claims, and location data in one platform with analyst overlay. | [PR Newswire, Nov 2022], [Benzinga, 2024] |
| YipitData | Alternative data aggregator focusing on consumer sectors via web scraping and partnerships. | Venture Scale (Series D in 2022) | Deep specialization in e-commerce and subscription economy data; large-scale web scraping operations. | [PitchBook] |
A competitive map for alternative data providers reveals distinct layers. At the data source layer, large financial institutions and payment networks like Visa and Mastercard offer direct feeds, but these are often expensive and lack cross-sector integration. At the aggregated platform layer, direct competitors like YipitData and Second Measure (acquired by Bloomberg) focus intensely on consumer transaction and web-scraped data. Earnest's declared wedge is its dual-sector coverage, combining its Orion and Vela credit card panels with medical claims (Hydrus) and prescription drug datasets [Neudata], [Pivot Investment Partners, 2025]. Adjacent substitutes include traditional equity research firms and consultancies, which provide analysis but lack proprietary, high-frequency data, and generalist business intelligence platforms like Bloomberg Terminal or FactSet, which aggregate third-party data but do not specialize in this granular alternative data.
Earnest's defensible edge appears rooted in its integrated data asset and its analyst-driven service model. The company's platform, Dash, is not merely a data pipe; it structures, visualizes, and provides point-in-time analytics, which is critical for quantitative backtesting [earnestanalytics.com, 2026]. This combination of curated datasets and analytical tools creates a workflow moat for investment professionals. However, this edge is perishable. Data partnerships are often non-exclusive, and the technical barrier to integrating disparate datasets, while significant, can be replicated by well-capitalized competitors or through industry consolidation, as evidenced by Earnest's own acquisition.
The company's most significant exposure lies in its reliance on third-party data partners and its relatively narrow geographic focus. While it cites "world-class data partners" [earnestanalytics.com], the lack of publicly named partners makes the durability of its data supply chain difficult to assess from the outside. A competitor with owned-and-operated data collection, such as YipitData's web-scraping infrastructure, may have more control over data cost and consistency. Furthermore, Earnest's focus is squarely on the U.S. market, leaving it vulnerable to global platforms that can offer multinational coverage, a gap its acquirer, Consumer Edge, may aim to fill.
The most plausible 18-month scenario post-acquisition involves integration and expansion. The "winner" will likely be the entity that most effectively bundles global transaction data with localized sector insights. If Consumer Edge successfully integrates Earnest's U.S. healthcare and consumer datasets into its global footprint, the combined entity could become a formidable, full-spectrum provider. Conversely, the "loser" could be standalone, single-sector data specialists that lack the capital or distribution to compete with bundled offerings. If market demand continues to shift toward platforms offering both global scale and deep vertical analytics, niche players without a clear path to either may face margin pressure or become acquisition targets themselves.
Data Accuracy: YELLOW -- Competitor YipitData confirmed via PitchBook; Earnest's positioning is well-documented, but the competitive map relies on sector analysis rather than direct public comparisons.
Opportunity
PUBLIC The prize for Earnest Analytics is the role of a primary intelligence layer for institutional capital, where its combined consumer and healthcare datasets become the standard for forward-looking investment decisions.
The headline opportunity is to become the category-defining alternative data platform for multi-sector investment strategies, a position validated by its strategic acquisition. The company's path is not speculative; it has already demonstrated the core product-market fit that attracted a strategic buyer in Consumer Edge, a firm that cited the need for "differentiated, data-driven intelligence, at scale" [PR Newswire, Sept 2024]. The opportunity lies in scaling this validated model beyond a single acquisition event. Earnest's unique wedge is its dual-sector coverage, integrating consumer transaction data with specialized healthcare claims, a combination that directly serves the increasing overlap in investment theses between consumer staples, retail, and healthcare services [PR Newswire, Nov 2022]. By already delivering this combined data through both an interactive platform and direct data feeds, the company has built the infrastructure to support this larger outcome [Benzinga, 2024].
Growth from this foundation could follow several concrete paths. The most plausible scenarios involve leveraging the company's existing assets and market position to capture adjacent customer segments or product categories.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Vertical Expansion in Healthcare | Earnest's healthcare data suite (Hydrus, prescription, procedure data) becomes the default for biopharma and medtech commercial analytics. | Successful adoption of the new Hydrus medical claims dataset launched in early 2025 [Pivot Investment Partners, 2025]. | The company has already built dedicated healthcare datasets and frames its mission around covering "the consumer and healthcare economy" [PR Newswire, Nov 2022]. |
| Platform-Led Land-and-Expand | The Dash interactive platform becomes the primary interface for analyst teams at asset managers, driving expansion from data subscriptions to enterprise-wide insight workflows. | A major contract with a top-tier hedge fund or mutual fund for firm-wide Dash access, displacing internal tools. | The platform is described as providing "powerful visualization, customization, and automation capabilities" specifically for investment professionals [Research.com, 2026]. |
| Embedded Data for Fintech | Earnest's aggregated data feeds become a white-label component embedded in next-generation investment research and portfolio tools for retail advisors and fintech platforms. | A strategic partnership with a major wealth management technology provider or data aggregator. | The company already delivers structured datasets via Snowflake and AWS, demonstrating an API-first, embeddable architecture [Benzinga, 2024]. |
Compounding for Earnest manifests as a data and insight flywheel. Each new client engagement generates proprietary queries and analysis patterns within the Dash platform. These patterns, anonymized and aggregated, can refine the platform's predictive models and pre-built analytics, making the product smarter for the next client. Furthermore, a growing and diverse client base across hedge funds, mutual funds, and private equity makes the company's aggregated benchmarks more statistically robust and valuable, creating a network effect in benchmark quality [earnestanalytics.com, 2026]. Evidence that this flywheel is spinning exists in the company's emphasis on "expert analysis" and custom insights as a core offering, suggesting they are already synthesizing client-driven intelligence into their service layer.
The size of the win can be framed by looking at the strategic value ascribed to comparable data intelligence platforms. While specific financials for Earnest's acquisition were not disclosed, the deal itself signals a high-value outcome in a consolidating market. A relevant public comparable is YipitData, a direct competitor in the alternative data space, which was valued at approximately $4 billion as of its last funding round in 2021 [PitchBook]. For Earnest, successfully executing on the healthcare vertical expansion or platform land-and-expand scenarios could see it command a similar premium as a standalone entity within a larger data conglomerate, or significantly increase its contribution to Consumer Edge's consolidated valuation. In a scenario where it becomes the dominant healthcare commercial intelligence platform, its value could approach a meaningful percentage of the multi-billion-dollar healthcare data analytics market (scenario, not a forecast).
Data Accuracy: YELLOW -- Growth scenarios are extrapolated from cited product launches and stated missions; the strategic acquisition is a confirmed, high-confidence anchor point.
Sources
PUBLIC
[PR Newswire (via Yahoo Finance syndication), Sept 2024] Consumer Edge to Acquire Earnest Analytics, Marking a New Era of Data‑Driven Intelligence for the Global Consumer Ecosystem | https://finance.yahoo.com/news/consumer-edge-acquire-earnest-analytics-163000210.html
[LinkedIn] Earnest Analytics | LinkedIn | https://www.linkedin.com/company/earnest-analytics
[PR Newswire, Nov 2022] EARNEST RESEARCH REBRANDS AS EARNEST ANALYTICS | https://www.prnewswire.com/news-releases/earnest-research-rebrands-as-earnest-analytics-301678883.html
[TechCrunch, Nov 2021] Sustain.Life launches to measure company carbon output, raises $7M pre-seed funding | TechCrunch | https://techcrunch.com/2021/11/17/sustain-life-launches-beta-to-measure-company-carbon-output-raises-7m-pre-seed-funding/
[Crunchbase] Earnest Analytics - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/earnest-analytics
[Crunchbase, 2026] Earnest Analytics - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/earnest-analytics
[G2, 2025] Earnest Analytics Products | https://www.g2.com/products/earnest-analytics/reviews
[Benzinga, 2024] Earnest Analytics' structured datasets are delivered daily to clients in the proprietary online interactive tool, Dash, as well as in aggregated and row-level data feeds though Snowflake and AWS. | https://www.benzinga.com/pressreleases/24/04/38254336/earnest-analytics-launches-new-medical-claims-dataset-hydrus
[Neudata] Neudata research | Earnest Analytics | https://webflow2.neudata.co/1/vendors/earnest-analytics
[earnestanalytics.com, 2026] Earnest Analytics | https://www.earnestanalytics.com/
[Pivot Investment Partners, 2025] Earnest Analytics launched a new medical claims dataset, Hydrus, on February 10, 2025. | https://www.pivotinvestmentpartners.com/insights/earnest-analytics-launches-hydrus-medical-claims-dataset
[Research.com, 2026] Earnest Dash provides powerful visualization, customization, and automation capabilities to transform raw data into actionable insights | https://research.com/software/earnest-analytics-review
[Built In San Francisco] Senior Analytics Engineer | https://www.builtinsf.com/job/senior-analytics-engineer/4233305
[Grand View Research, 2023] Alternative Data Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/alternative-data-market-report
[PitchBook] YipitData 2026 Company Profile: Valuation, Funding & Investors | PitchBook | https://pitchbook.com/profiles/company/13431-79
Articles about Earnest Analytics
- Earnest Analytics Crosses from Credit Cards to Medical Claims — The New York alt-data firm, acquired by Consumer Edge, now stakes its bet on unifying consumer and healthcare spending for investors.